Tools & Techniques: siRNA Delivery to Endothelia; miRNA Analysis in Non-Model Animals; and More | GenomeWeb

With an eye toward applying RNAi to the treatment of disorders associated with injured endothelial cells, a team of researchers from Huazhong University of Science and Technology has reported on novel nanoparticles capable of delivering siRNAs into such cells in the brain.

Brain microvascular endothelial cells, or BMECs, act as a barrier to pathogens in the brain, and injury to these cells is associated with the development of a variety of diseases including stroke and atherosclerosis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.